- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Harvard Stem Cell Institute
Headquarters: Cambridge, MA, United States
Website: http://hsci.harvard.edu
Year Founded: 2004
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Jul 13, 2023
Management Tracks
Howard Horn named CFO at Ultragenyx
Plus: Elizabeth Carpenter joins PhRMA, and updates from Garuda, SIRPant and Brainstorm
BioCentury | Dec 22, 2021
Emerging Company Profile
Clade: immune-cloaked, iPSC-derived cell therapies
Syncona’s first allogeneic cell therapy investment goes to Clade, led by Sana and CRISPR Therapeutics co-founder Cowan
BioCentury | Sep 24, 2021
Product Development
Sept. 23 Quick Takes: $72M series A for stem cell newco Garuda
Plus: On deck at ODAC, GenEdit, Worg-Apitope, Reata, Tyvyt and more
BioCentury | Jul 2, 2021
Distillery Therapeutics
SHH, YAP1 inhibition for genetic, acquired heterotopic ossification
DISEASE CATEGORY: Musculoskeletal
INDICATION: Bone repair Targeting the hedgehog ligand SHH or YAP1, which drives SHH expression, could treat both genetic and acquired forms of heterotopic
INDICATION: Bone repair Targeting the hedgehog ligand SHH or YAP1, which drives SHH expression, could treat both genetic and acquired forms of heterotopic
BioCentury | Feb 27, 2021
Translation in Brief
A $53M UC Berkeley-UCSF-Genentech-Roche collaboration on brain diseases; plus Selecta, JDRF-Harvard Stem Cell Institute, Tissue Dynamics and more
BioCentury’s roundup of translational news
BioCentury | Sep 3, 2019
Company News
Via $950M Semma takeout, Vertex moves into diabetes and cell therapy
BioCentury | Mar 26, 2019
Company News
Sana adds hypoimmunogenic stem cell tech from Harvard to its tool kit
BioCentury | Dec 1, 2017
Finance
Semma prepares to deliver
How Semma will continue its transition from lab to clinic with a $114M series B
BioCentury | Aug 17, 2017
Translation in Brief
Dispersing brain metastases
Oncolytic HSV-loaded MSCs could treat dispersed brain metastases in melanoma
Items per page:
1 - 10 of 44